Abstract:Transient receptor potential melastatin 2 (TRPM2), a non-selective cation channel, is involved in many physiological and pathological processes, including temperature sensing, synaptic plasticity regulation, and neurodegenerative diseases. However, the gating mechanism of TRPM2 channel is complex, which hinders its functional research. With the discovery of the Ca2+ binding site in the S2-S3 domain of TRPM2 channel, more and more attention has been drawn to the role of the transmembrane segments in channel gating. In this study, we focused on the D820-F867 segment around the S2 domain, and identified the key residues on it. Functional assays of the deletion mutants displayed that the deletions of D820-W835 and L836-P851 destroyed channel function totally, indicating the importance of these two segments. Sequence alignments on them found three polar and charged residues with high conservation (D820, E829, and R845). D820A, E829A, and R845A which removed the charge and the side chain of the residues were tested by 500 mu M adenosine diphosphate-ribose (ADPR) or 50 mM Ca2+. E829A and R845A affected the characteristic of channel currents, while D820A behaved similarly to WT, indicating the participations of E829 and R845 in channel gating. The charge reversing mutants, E829K and R845D were then constructed and the electrophysiological tests showed that E829A and E829K made the channel lose function. Interestingly, R845A and R845D exhibited an inactivation process when using 500 mu M ADPR, but activated normally by 50 mM Ca2+. Our data suggested that the negative charge at E829 took a vital part in channel activation, and R845 increased the stability of the Ca2+ combination in S2-S3 domain, thus guaranteeing the opening of TRPM2 channel. In summary, our identification of the key residues E829 and R845 in the transmembrane segments of TRPM2. By exploring the gating process of TRPM2 channel, our work helps us better understand the mechanism of TRPM2 as a potential biomarker in neurodegenerative diseases, and provides a new approach for the prediction, diagnosis, and prognosis of neurodegenerative diseases.

Identification of a drug binding pocket in TMEM16F calcium-activated ion channel and lipid scramblase

Cryo-EM Studies of TMEM16F Calcium-Activated Ion Channel Suggest Features Important for Lipid Scrambling

Identification of a druggable pocket of the calcium-activated chloride channel TMEM16A in its open state

Niclosamide potentiates TMEM16A and induces vasoconstriction

Activation of TMEM16F by Inner Gate Charged Mutations and Possible Lipid/ion Permeation Mechanisms.

Stepwise activation mechanism of the scramblase nhTMEM16 revealed by cryo-EM

Revisiting the Mechanism of TMEM16F Phospholipid Scramblase Inhibition by Small Molecules

Phosphatidylinositol-(4, 5)-bisphosphate regulates calcium gating of small-conductance cation channel TMEM16F

TMEM16 proteins: Ca2+‑activated chloride channels and phospholipid scramblases as potential drug targets (Review)

Structural and theoretical basis for drug development targeting TMEM16A: Inhibition mechanism of tracheloside analogs

A comprehensive search for calcium binding sites critical for TMEM16A calcium-activated chloride channel activity

Structural basis of closed groove scrambling by a TMEM16 protein

Molecular mechanism of CaCCinh-A01 inhibiting TMEM16A channel

In or out of the groove? Mechanisms of lipid scrambling by TMEM16 proteins

The identification of the key residues E829 and R845 involved in transient receptor potential melastatin 2 channel gating

Structural basis for inhibition of the lysosomal two-pore channel TPC2 by a small molecule antagonist

TMEM16 scramblases thin the membrane to enable lipid scrambling

Membrane structure-responsive lipid scrambling by TMEM63B to control plasma membrane lipid distribution

Tmem16F Forms a Ca2+-Activated Cation Channel Required for Lipid Scrambling in Platelets During Blood Coagulation

TMEM16 and OSCA/TMEM63 proteins share a conserved potential to permeate ions and phospholipids